Denosumab

Denosumab is a medicine used to help prevent bone loss. It's given as an injection. It works by stopping the body from breaking down bone, which helps keep bones strong.

Brand names:Prolia, Xgeva
Medication

What people taking Denosumab report

Every report comes from a Lived member, sent anonymously.

Have you tried Denosumab for Osteoporosis?

NameHow it went

About Denosumab

What It's For

Denosumab is a prescription injection that strengthens bone by slowing the rate at which the body breaks it down. It is sold under two main brand names that use different doses for different purposes. Prolia treats osteoporosis, the thinning and weakening of bone that makes fractures more likely. It is approved for postmenopausal women and for men with osteoporosis who are at high risk of a fracture, usually because they have already broken a bone, have several risk factors, or could not take or did not benefit from another osteoporosis medicine. It is also used for bone loss caused by long-term steroid medicines such as prednisone, and for bone loss caused by hormone-blocking cancer treatments: androgen deprivation therapy for prostate cancer and aromatase inhibitors for breast cancer. Xgeva is used in cancer care. It helps prevent fractures and other bone complications in people with multiple myeloma or with cancer that has spread to the bones. It also treats giant cell tumor of bone (a rare, usually noncancerous bone tumor) when surgery is not a good option, and high blood calcium caused by cancer when bisphosphonate medicines have not worked. Other denosumab products, such as Jubbonti (with the same uses as Prolia) and Wyost (with the same uses as Xgeva), are also available. They contain the same active ingredient, so a person should not receive two denosumab products at the same time.

How It Works

Bone is living tissue that is constantly rebuilt. Cells called osteoclasts break down old bone while other cells lay down new bone. In osteoporosis, and in some cancers that affect the skeleton, breakdown outpaces rebuilding and bone becomes weaker. Osteoclasts need a signaling protein called RANK ligand (RANKL) to form, work and survive. Denosumab is a laboratory-made antibody that attaches to RANKL and stops it from switching osteoclasts on. With fewer active osteoclasts, bone breakdown slows, bone density rises and bones become stronger and less likely to break. When bone breakdown is the source of high calcium in the blood, slowing it also brings calcium levels down. This effect wears off as the medicine leaves the body over the months after each dose, which is why injections must stay on schedule.

Dosage & Administration

Denosumab is given as an injection under the skin of the upper arm, upper thigh or abdomen, by a healthcare provider. It is not a pill and is not given into a vein. For osteoporosis and treatment-related bone loss, Prolia is given as 60 mg once every 6 months. If a dose is missed, it should be given as soon as possible, and the next injections are then scheduled 6 months from that date. For cancer-related bone disease, Xgeva is given at a higher dose, 120 mg every 4 weeks. For giant cell tumor of bone and cancer-related high calcium, extra doses are added on days 8 and 15 of the first month. Because denosumab can lower blood calcium, low calcium has to be corrected before treatment begins. People on Prolia are generally asked to take daily calcium and vitamin D supplements, and people on Xgeva take them as their care team directs. Women who could become pregnant have a pregnancy test before starting.

Side Effects

With Prolia, the most commonly reported problems in studies of osteoporosis were back pain, pain in the arms or legs, and muscle or joint pain, along with bladder infections and higher cholesterol. Skin problems such as rash, eczema and dry, itchy skin also occur more often than with placebo. With Xgeva in cancer care, tiredness, nausea and low blood phosphate are common. Low blood calcium is the side effect to know about. Most people with low calcium have no symptoms, so blood tests matter, but muscle spasms, twitching or cramps, or numbness and tingling in the fingers, toes or around the mouth should be reported to the care team right away. Some less common problems also need a prompt call: signs of a serious infection, such as fever or chills, skin that is red, swollen, hot or tender, or burning when urinating; severe bone, joint or muscle pain; and new or unusual pain in the thigh, hip or groin, which can be an early sign of an uncommon type of thigh bone fracture. A serious allergic reaction, with trouble breathing, throat tightness or swelling of the face, lips or tongue, needs emergency care.

Interactions & Warnings

Prolia carries the US Food and Drug Administration's (FDA's) most serious warning, a boxed warning, for people with advanced chronic kidney disease, meaning an estimated glomerular filtration rate (eGFR, a blood-test estimate of kidney function) below 30, including people on dialysis. In this group denosumab can cause severe drops in calcium that have led to hospitalization and death, especially when chronic kidney disease-mineral and bone disorder (CKD-MBD), a disturbance of bone and mineral balance caused by kidney failure, is present. Before treatment, these patients need testing for that disorder, and treatment should be supervised by a specialist, with calcium checked weekly for the first month and monthly after that. Xgeva's label also notes a higher risk of low calcium with severe kidney disease. Calcimimetics, a group of medicines that lower calcium and parathyroid hormone levels, and other calcium-lowering drugs can add to the risk. Denosumab can rarely cause osteonecrosis of the jaw, where an area of jawbone loses its blood supply and fails to heal. The risk is higher after tooth extractions or other dental surgery, with poor oral health, in people with cancer, and with longer or higher-dose treatment. A mouth exam, and often a dental checkup, is advised before starting. Keep up good oral hygiene, tell any dentist about the medicine before a procedure, and report jaw pain or slow healing in the mouth. Denosumab is not used in pregnancy because it can harm a developing baby. Women who could become pregnant should use effective contraception during treatment and for at least 5 months after the last dose. It is also not used in anyone who has had a serious allergic reaction to a denosumab product.

What to Expect

Denosumab works quietly. Most people feel nothing different, and the benefit shows up as higher bone density on scans and fewer fractures over time. In the main 3-year trial in postmenopausal women with osteoporosis, new spine fractures seen on x-ray occurred in about 2 in 100 women on denosumab compared with about 7 in 100 on placebo, and hip and other fractures were also reduced. Follow-up usually includes periodic bone density scans and blood calcium checks, more closely for people with kidney disease or other reasons for low calcium. The most important practical point is what happens when denosumab stops. Its effect fades within months, bone breakdown rebounds above the starting level, and the bone density gained is lost within about 18 months. During this rebound, some people develop several spine fractures at once, as early as 7 months after the last injection, and the risk is higher in people who have already had a spine fracture. For this reason Prolia should not be stopped, skipped or delayed without a plan, and if it is stopped, a doctor will usually switch to another bone-protecting medicine, such as a bisphosphonate, to hold the gains. People stopping Xgeva also need their spine fracture risk reviewed, and people with giant cell tumor of bone, or with a still-growing skeleton, are watched for high calcium during the year after stopping.

Questions to Ask Your Doctor

  1. 1.Why is denosumab a better fit for me than a bisphosphonate or another bone medicine?
  2. 2.If I ever stop denosumab, what medicine will we use afterward to protect my spine, and when would it start?
  3. 3.Does my kidney function or any other condition raise my risk of low calcium, and how often will my calcium be checked?
  4. 4.Should I see my dentist before starting, and how should we handle any dental work I need during treatment?
  5. 5.How will we judge whether the medicine is working, and how long do you expect me to stay on it?

Last reviewed • Oct 2026

Educational content, not medical advice.